Hawkins, Inc. (HWKN) is a publicly traded company in the Basic Materials — Chemicals - Specialty industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition.
Is Hawkins, Inc. stock overvalued or undervalued in 2026?
Hawkins, Inc. (HWKN) trades at 37.0× earnings (P/E), above the median of the 156 materials companies over $2bn in Kaplio's universe. At the decade median (20.5×) $84 (-45 %); at its sector median (18.6×) $76 (-50 %).
Kaplio overview: Hawkins, Inc.
Market cap $3B · 52 weeks $118 – $172 (11 % below the high) · P/E 37.0× · 2027 est. P/E 36.7× · Dividend 0.50 % · 6 years rising · Next earnings January 27, 2027 · expected EPS $0.72 · Closing price, Oct 30 · accounts published Oct 26.
- Valuation: TTM P/E 37.0× (expensive).
- Business: ROIC 10 % (fair).
- Balance sheet: Net debt/EBITDA 1.5× (solid).
- Earnings: 3 of 8 (disappointing).
What would it be worth at its usual multiples?
At the decade median (20.5×) $84 (-45 %); at its sector median (18.6×) $76 (-50 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in materials: 4 of 8 pass
- FCF yield 2.1 %, fails.
- Gross margin 20.6 %, fails.
- P/B across cycles 5.6×, fails.
- Cycle-adjusted EV/EBITDA 18.6×, fails.
- Net debt / EBITDA (trough) 1.5×, passes.
- Dividend coverage 5.5×, passes.
- Capex / D&A 1.1×, passes.
- Altman Z-Score 6.3, passes.
Against its peers (reference peers) — Hawkins, Inc.: P/E 37.0×; EV/EBITDA 18.6×; ROIC 9.9 %; $3.2B. Ashland Inc. (P/E 66.1×; EV/EBITDA 11.7×; ROIC 1.9 %; $3.4B), Avient Corporation (P/E 23.2×; EV/EBITDA 10.7×; ROIC 4.7 %; $3.9B), Ingevity Corporation (P/E 50.6×; EV/EBITDA 19.0×; ROIC 12.3 %; $2.6B).
Expensive or cheap against its last ten years?
P/E at each close: today 37.0× · median 20.4× · minimum 13.5× · maximum 45.1× · cheap below 18.3× · expensive above 31.6×. It has been cheaper than today 92% of the time over its last ten years.
Dividend
solid · Yield 0.50 % ($0.76 per share in 2026) · Years raising it 6 · 5-year growth +10 % a year · Free cash flow coverage 6.3× · With $1,000 invested today you'd collect $5.00 a year ($0.42 a month).
Profitability
| Return on Equity | 15.86% |
| Return on Invested Capital | 9.93% |
| Return on Assets | 8.48% |
| Gross Margin | 22.44% |
| Operating Margin | 10.66% |
| Net Margin | 7.53% |
Financial Health
| Debt / Equity | 0.44 |
| Current Ratio | 2.28 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 6.35 |
Price Performance
| 1 month | +16.07% |
| 3 months | +14.09% |
| Year-to-date | +7.37% |
| 1 year | +7.53% |
| 3 years | +151.87% |
| 5 years | +307.40% |
| 10 years | +665.33% |
Dividend History
Paid in the last 12 months: $0.77 per share in 4 payments.
| Date | Amount |
|---|---|
| November 10, 2026 | $0.20 |
| August 14, 2026 | $0.20 |
| May 29, 2026 | $0.19 |
| February 13, 2026 | $0.19 |
| November 14, 2025 | $0.19 |
| August 15, 2025 | $0.19 |
| May 30, 2025 | $0.18 |
| February 14, 2025 | $0.18 |
| November 15, 2024 | $0.18 |
| August 16, 2024 | $0.18 |
Amounts adjusted for stock splits.
Related companies: BCPC · IOSP · IFF · ESI · EMN · NEU · AVNT · NGVT
Explore sector: Basic Materials · Chemicals - Specialty
More sections of HWKN: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks